A.ö. Landeskrankenhaus Leoben
About A.ö. Landeskrankenhaus Leoben
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Arbeitsgemeinschaft medikamentoese Tumortherapie
6
Austrian Breast & Colorectal Cancer Study Group
5
Clinical Trials at A.ö. Landeskrankenhaus Leoben
During the past decade, A.ö. Landeskrankenhaus Leoben conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
1999-06-01
2018-06-26
Completed
1,803
Preoperative Chemoradiation With Capecitabine and Cetuximab
2005-10-01
2011-11-01
Completed
31
Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B
1993-11-01
Completed
636
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
2005-02-01
2011-11-01
Completed
536
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
2006-01-01
2013-03-01
Completed
683
A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response
2004-03-01
2008-02-13
Completed
10
Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma
2007-12-01
2012-01-01
Completed
94
Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma
2008-08-01
2012-12-01
Terminated
50
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "A.ö. Landeskrankenhaus Leoben"
#1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "Sanofi" with 3 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Cephalon" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at A.ö. Landeskrankenhaus Leoben
According to Clinical.Site data, the most researched conditions in "A.ö. Landeskrankenhaus Leoben" are
"Breast Cancer" (3 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Colon Cancer Stage II" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Diffuse Large B-Cell Lymphoma (DLBCL)" (1 trials). Many other conditions were trialed in "A.ö. Landeskrankenhaus Leoben" in a lesser frequency.
Clinical Trials Intervention Types at A.ö. Landeskrankenhaus Leoben
Most popular intervention types in "A.ö. Landeskrankenhaus Leoben" are "Drug" (11 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Alemtuzumab" (2 trials), "Capecitabine" (2 trials), "Cetuximab" (2 trials), "Rituximab" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.
Clinical Trials Genders at A.ö. Landeskrankenhaus Leoben
The vast majority of trials in "A.ö. Landeskrankenhaus Leoben" are
9 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at A.ö. Landeskrankenhaus Leoben
Currently, there are NaN active trials in "A.ö. Landeskrankenhaus Leoben".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in A.ö. Landeskrankenhaus Leoben,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in A.ö. Landeskrankenhaus Leoben, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".